Ancilia Biosciences, Inc.
Biotechnology company · New York, United States
Ancilia Biosciences, Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2019. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $274,401 in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2023.
Ancilia Biosciences at a glance
What does Ancilia Biosciences do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $274,401 in total (2024). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $1 million sold (2023).
Frequently asked questions about Ancilia Biosciences
Where is Ancilia Biosciences headquartered?
Ancilia Biosciences, Inc. is headquartered in New York, United States.
What does Ancilia Biosciences do?
Ancilia Biosciences, Inc. is a biotechnology company.
When was Ancilia Biosciences founded?
The earliest incorporation on record for Ancilia Biosciences, Inc. is in 2019, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Microstructure Imaging, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.